ClinicalTrials.govpublic full text
Evaluation of Xaluritamig in High-Risk, Biochemically Recurrent, Non-metastatic Castrate-sensitive Prostate Cancer
prostate cancer, high-risk biochemical recurrence, high risk biochemical recurrence of non-metastatic castration-sensitive prostate cancer, non-metastatic castration-sensitive prostate cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 366604
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.